KA

Kabeer Aziz

Partner at Adjuvant Capital

New York, New York

Overview

Work Experience

AC

Adjuvant Capital

  • Partner

    2018 - Current

    Leading life sciences investment fund focused on global public health Board of Directors: AN2 Therapeutics, MinervaX, Pulmocide, Quantoom Biosciences, Frontier Nutrition Board Observer: YS Biopharma (2020-2022), Themis (2018-2020)

GH

Global Health Investment Fund

  • Senior Associate

    2015 - 2018

    Impact investing to finance global health research & development

MC

Metalmark Capital

  • Associate

    2013 - 2015

    Private / Growth Equity (Healthcare)

G&

Greenhill & Co.

  • Analyst

    2010 - 2013

    Mergers & Acquisitions (Pharma and MedTech)

Education

Investments

Minervax

Series B

Total Funding: $140M

LimmaTech Biologics

Series A

Total Funding: $36M

Pulmocide

Series C

Total Funding: $140M

Relevant Websites